For obesity, its default state of low-grade, chronic inflammation and disordered immune function [12] severely lowers nicotinamide adenine dinucleotide (NAD+) at cellular, tissue, and systemic levels, leading to restricted cellular energy production [13]
Patients who reduce refined carbohydrates and dietary saturated fat while on GLP-1 treatment tend to see stronger lipid improvements than those who rely on the medication alone
Em um estudo de fase 2, pacientes com Alzheimer em estgios iniciais que receberam liraglutida apresentaram uma reduo de quase 50% no ritmo de encolhimento cerebral em reas crticas como o lobo temporal, frontal e parietal e uma reduo de 18% no declnio cognitivo, se comparados aos que receberam placebo (Edison, 2024)
Semaglutide is a type of medication that falls into a group called GLP-1 RAs
The recommended duration of use is three to four sessions per month